Condition
Injections
Total Trials
6
Recruiting
0
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (4)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Active Not Recruiting2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05510492Not ApplicableCompletedPrimary
Effect of Training on IM Injection Practices
NCT06761456Not ApplicableActive Not RecruitingPrimary
Parenteral Injection Training Module
NCT04094298Phase 3Active Not Recruiting
Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease
NCT04851158Not ApplicableCompletedPrimary
Effectiveness of Two Different Methods During Intramuscular Antibiotic Injection: ShotBlocker, Local Vibration
NCT04029389Not ApplicableUnknown
Ultrasound-Guided Tibial Nerve Block vs. Local Corticosteroid Injection in Recalcitrant Plantar Fasciitis Treatment
NCT00410891Phase 4Completed
Topical Antibiotics and Intravitreous Injections
Showing all 6 trials